• Guideline Summary
  • NGC:010730
  • 2013 Apr (revised 2015 Apr)

Castration-resistant prostate cancer: AUA guideline.

  • Guideline Summary
  • NGC:011058
  • 2016

ACR Appropriateness Criteria® osteoporosis and bone mineral density.

  • Guideline Summary
  • NGC:010672
  • 1996 (revised 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

  • Guideline Summary
  • NGC:010470
  • 1996 (revised 2014)

ACR Appropriateness Criteria® postradical prostatectomy irradiation in prostate cancer.

  • Guideline Summary
  • NGC:010892
  • 2016 Jan 27

Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases.

  • Guideline Summary
  • NGC:010961
  • 2016 Apr 27

Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated.

  • Guideline Summary
  • NGC:010496
  • 2014 Jul

Enzalutamide for metastatic hormone-relapsed prostate cancer previously treated with a docetaxel-containing regimen.

  • Guideline Summary
  • NGC:010893
  • 2016 Jan 27

Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated.

  • Guideline Summary
  • NGC:009376
  • 2012 Oct

Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.